日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Efficacy and Pharmacokinetics of Fosmanogepix (APX001) in the Treatment of Candida Endophthalmitis and Hematogenous Meningoencephalitis in Nonneutropenic Rabbits

Fosmanogepix (APX001) 治疗非中性粒细胞减少兔念珠菌性眼内炎和血源性脑膜脑炎的疗效和药代动力学

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.01795-20
Petraitiene, Ruta; Petraitis, Vidmantas; Maung, Bo Bo Win; Mansbach, Robert S; Hodges, Michael R; Finkelman, Malcolm A; Shaw, Karen Joy; Walsh, Thomas J
脑炎
中性粒细胞
Rabbit
神经科学
粒细胞
细胞生物学
发表日期：2021
文献求助 收藏

Antifungal efficacy of isavuconazole and liposomal amphotericin B in a rabbit model of Exserohilum rostratum meningoencephalitis: A preclinical paradigm for management of CNS phaeohyphomycosis

伊沙康唑和脂质体两性霉素B在兔脑膜脑炎模型中的抗真菌疗效：中枢神经系统嗜色真菌病治疗的临床前范例

期刊:Medical Mycology
影响因子:2.3
doi:10.1093/mmy/myaa102
Petraitis, Vidmantas; Petraitiene, Ruta; Katragkou, Aspasia; Maung, Bo Bo Win; Moradi, Patriss W; Sussman-Straus, Gittel E; Naing, Ethan; Kovanda, Laura L; Finkelman, Malcolm A; Walsh, Thomas J
微生物学
脑炎
神经科学
发表日期：2021
文献求助 收藏

Combination Therapy with Ibrexafungerp (Formerly SCY-078), a First-in-Class Triterpenoid Inhibitor of (1→3)-β-d-Glucan Synthesis, and Isavuconazole for Treatment of Experimental Invasive Pulmonary Aspergillosis

伊布沙芬普（Ibrexafungerp，原名 SCY-078，一种首创的三萜类 (1→3)-β-D-葡聚糖合成抑制剂）与伊沙康唑联合治疗实验性侵袭性肺曲霉病

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.02429-19
Petraitis, Vidmantas; Petraitiene, Ruta; Katragkou, Aspasia; Maung, Bo Bo Win; Naing, Ethan; Kavaliauskas, Povilas; Barat, Stephen; Borroto-Esoda, Katyna; Azie, Nkechi; Angulo, David; Walsh, Thomas J
发表日期：2020
文献求助 收藏

Pharmacokinetics and Tissue Distribution of Minocycline following Intravenous Administration in Rabbits

米诺环素静脉注射后在兔体内的药代动力学和组织分布

期刊:
影响因子:
doi:10.1177/23992026211052272
Naughton, Bernard David; Akgul, Ebru; Petraitis, Vidmantas; Petraitiene, Ruta; Maung, Bo Bo Win; Nolan, Tom G; Griffith, David C; Dudley, Michael N; Walsh, Thomas J
Rabbit
发表日期：2017
文献求助 收藏